Literature DB >> 25354219

How can we improve oral contraceptive success in obese women?

Ganesh Cherala1, Alison Edelman.   

Abstract

A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.

Entities:  

Keywords:  drug failure; obesity; oral contraception; pharmacokinetics; steroidal hormones

Mesh:

Substances:

Year:  2014        PMID: 25354219      PMCID: PMC4581527          DOI: 10.1586/17512433.2015.974558

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  15 in total

1.  Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.

Authors:  Lawrence B Finer; Stanley K Henshaw
Journal:  Perspect Sex Reprod Health       Date:  2006-06

2.  Oral contraceptive effectiveness according to body mass index, weight, age, and other factors.

Authors:  Jürgen C Dinger; Maureen Cronin; Sabine Möhner; Ilka Schellschmidt; Thai Do Minh; Carolyn Westhoff
Journal:  Am J Obstet Gynecol       Date:  2009-05-30       Impact factor: 8.661

3.  Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women.

Authors:  Carolyn L Westhoff; Anupama H Torgal; Elizabeth R Mayeda; Malcolm C Pike; Frank Z Stanczyk
Journal:  Contraception       Date:  2010-02-20       Impact factor: 3.375

4.  Unintended pregnancy and taxpayer spending.

Authors:  Emily Monea; Adam Thomas
Journal:  Perspect Sex Reprod Health       Date:  2011-05-19

5.  Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics.

Authors:  Maciej J Zamek-Gliszczynski; Jeffrey S Day; Kathleen M Hillgren; Diane L Phillips
Journal:  Drug Metab Dispos       Date:  2011-06-27       Impact factor: 3.922

6.  Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen.

Authors:  Jürgen Dinger; Thai Do Minh; Nina Buttmann; Kristina Bardenheuer
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

7.  Use of contraception and use of family planning services in the United States: 1982-2002.

Authors:  William D Mosher; Gladys M Martinez; Anjani Chandra; Joyce C Abma; Stephanie J Willson
Journal:  Adv Data       Date:  2004-12-10

8.  Body mass index, weight, and oral contraceptive failure risk.

Authors:  Victoria L Holt; Delia Scholes; Kristine G Wicklund; Kara L Cushing-Haugen; Janet R Daling
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

9.  Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.

Authors:  Alison B Edelman; Nichole E Carlson; Ganesh Cherala; Myrna Y Munar; Richard L Stouffer; Judy L Cameron; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2009-06-04       Impact factor: 3.375

Review 10.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.